Μάλτα - Αγγλικά - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - roxithromycin - coated tablet - roxithromycin 150 mg - antibacterials for systemic use

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - roxithromycin -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - roxithromycin -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - roxithromycin -

Ισραήλ - Αγγλικά - Ministry of Health

unipharm ltd, israel - roxithromycin - tablets - roxithromycin 150 mg - roxithromycin - for the treatment of infections caused by microorganisms sensitive to roxithromycin e.g: ent bronchopulmonary, genital and skin manifestations.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - roxithromycin -

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol laboratories ltd - domperidone maleate - oral tablet - 10mg

Μαλαισία - Αγγλικά - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

imeks pharma sdn. bhd. - roxithromycin -

Νότια Αφρική - Αγγλικά - South African Health Products Regulatory Authority (SAHPRA)

hexal -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: purified talc; colloidal anhydrous silica; hypromellose; titanium dioxide; magnesium stearate; povidone; hyprolose; glucose; maize starch; propylene glycol; poloxamer - for the treatment of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms in; acute pharyngitis, tonsillitis, and sinusitis. acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia (including atypical pneumonia). skin and soft tissue infections and non-gonococcal urethritis